13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001839209
Total reported value
$3.8B
$3.8B
6 檔
100.2%
The Q1 2026 SEC filing reveals that Darwin Global Management, Ltd. held a total portfolio value of $3.8B, covering 6 public equity positions.
Darwin Global Management, Ltd. executed strategic sector rebalancing during Q1 2026, establishing 3 new positions while fully exiting 3 holdings and trimming 1 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | Stock-Healthcare | 68.33% | -50.42% | -19.72% | |
| 2 | BLTE | Belite Bio Inc - Adr | Stock-Other | 12.10% | +0.04% | +0.98% | |
| 3 | ABVX | Abivax Sa-adr | Stock-Other | 9.34% | -0.08% | +9.13% | |
| 4 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 5.44% | +49.01% | — | |
| 5 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 4.76% | +1.47% | — | |
| 6 | DNTH | Dianthus Therapeutics Inc | Stock-Other | 0.04% | -0.04% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BLTE | Belite Bio Inc - Adr | +2.2% | +0.98% | Add |
| 2 | ABVX | Abivax Sa-adr | +0.4% | +9.13% | Add |
| 3 | INSM | Insmed Inc | -5.5% | -19.72% | Trim |
| 4 | CDTX | Cidara Therapeutics Inc | — | EXIT | Sold out |
| 5 | RVMD | Revolution Medicines Inc | — | NEW | New buy |
| 6 | ROIV | Roivant Sciences Ltd. | — | NEW | New buy |
| 7 | WVE | Wave Life Sciences Ltd. | — | EXIT | Sold out |
| 8 | CAPR | Capricor Therapeutics Inc | — | EXIT | Sold out |
| 9 | DNTH | Dianthus Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Darwin Global Management, Ltd. reported a total U.S. public equity portfolio value of $3.8B across 6 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including INSM, BLTE, ABVX) accounted for 100.2% of total reported equity market value during Q1 2026.
Top New Position Initiated
RVMD
市值: $205.0M
Top Position Liquidated / Trimmed
CDTX
前期市值: $220.2M
During Q1 2026, Darwin Global Management, Ltd.'s top holdings by market value included INSM (68.3%)、BLTE (12.1%)、ABVX (9.3%). The largest single position, INSM, represented 68.3% of total portfolio value.
In Q1 2026, Darwin Global Management, Ltd. made 9 total portfolio adjustments, initiating 3 new buys, adding to 2 positions, trimming 1 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.